Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication

被引:455
作者
Pisella, PJ
Pouliquen, P
Baudouin, C
机构
[1] Univ Paris 05, Dept Ophthalmol, APHP Ambroise Pare Hosp, F-92100 Boulogne, France
[2] CHU Bretonneau, Dept Ophthalmol, F-37044 Tours 1, France
[3] Thea Labs, F-63017 Clermont Ferrand 2, France
[4] Univ Paris 05, Natl Hosp 15 20, F-75012 Paris, France
关键词
D O I
10.1136/bjo.86.4.418
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: To determine the incidence of ocular toxicity of preservatives with glaucoma medications. Methods: A prospective epidemiological survey was carried out in 1999 by 249 ophthalmologists on A 107 patients. Ocular symptoms, conjunctiva, cornea, and eyelids were assessed. A chi(2) test was used for differences between preserved eye drops (P) and preservative free eye drops (PIP). Results: 84% patients used P, 13% received PF, and 3% a combination of P and PF eye drops. All symptoms were more prevalent with P than with PF drops (p<0.001): discomfort upon instillation (43% versus 17%), and symptoms between instillations such as burning-stinging (40% versus 22%), foreign body sensation (31% versus 14%), dry eye sensation (23% versus 14%), tearing (21% versus 14%), and eyelid itching (18% versus 10%). An increased incidence (>2 times) of ocular signs was seen with P eye drops. The prevalence of signs and symptoms was dose dependent, increasing with the number of P drops. A reduction in the symptoms and signs was observed when patients changed from P to PF eye drops (p<0.001). Conclusions: Symptoms and signs are less prevalent when PF drops are used. Moreover, most of the adverse reactions induced by P glaucoma medication are reversible after removing preservatives.
引用
收藏
页码:418 / 423
页数:6
相关论文
共 53 条
[41]   THE EFFECT OF PRESERVATIVES AND ANTIGLAUCOMATOUS MEDICATION ON THE HISTOPATHOLOGY OF THE CONJUNCTIVA [J].
MIETZ, H ;
NIESEN, U ;
KRIEGLSTEIN, GK .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1994, 232 (09) :561-565
[42]   TRABECULECTOMY COMBINED WITH BETA-IRRADIATION FOR CONGENITAL GLAUCOMA [J].
MILLER, MH ;
RICE, NSC .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1991, 75 (10) :584-590
[43]  
NORN MS, 1977, ACTA OPHTHALMOL, V55, P23
[44]   Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits [J].
Pisella, PJ ;
Fillacier, K ;
Elena, PP ;
Debbasch, C ;
Baudouin, C .
OPHTHALMIC RESEARCH, 2000, 32 (01) :3-8
[45]  
Rolando M, 1991, S LACR SYST SING MAR, P87
[46]   LONG-TERM MORPHOLOGIC EFFECTS OF ANTIGLAUCOMA DRUGS ON THE CONJUNCTIVA AND TENONS CAPSULE IN GLAUCOMATOUS PATIENTS [J].
SHERWOOD, MB ;
GRIERSON, I ;
MILLAR, L ;
HITCHINGS, RA .
OPHTHALMOLOGY, 1989, 96 (03) :327-335
[47]  
TAKAHASHI N, 1982, JPN J OPHTHALMOL, V26, P234
[48]   Incidence of ocular side effects of topical β blockers in the Netherlands [J].
van Beek, LM ;
de Keizer, RJW ;
Polak, BCP ;
Elzenaar, PR ;
van Haeringen, NJ ;
Kijlstra, A .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (08) :856-859
[49]  
WILLIAMS DE, 1992, INVEST OPHTH VIS SCI, V33, P2233
[50]   ADVERSE EXTERNAL OCULAR EFFECTS OF TOPICAL OPHTHALMIC MEDICATIONS [J].
WILSON, FM .
SURVEY OF OPHTHALMOLOGY, 1979, 24 (02) :57-88